KRRO
Korro Bio, Inc.
There isn't enough reported data to score KRRO yet.
KRRO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Unavailable |
KRRO's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.
KRRO PE Valuation
KRRO has no meaningful PE right now: it lost money over the past year.
KRRO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect KRRO's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
KRRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$9.07 | +$0.32 |
| Q2 2026 | -$10.01 | -$0.28 |
| Q1 2026 | -$11.68 | -$2.26 |
| Q4 2025 | -$12.48 | -$3.11 |
| Q3 2025 | -$9.39 | +$49.67 |
| Q2 2025 | -$9.73 | +$62.57 |
| Q1 2025 | -$9.42 | +$75.23 |
| Q4 2024 | -$9.37 | +$100.17 |
KRRO is still losing money, but far less than before: $9.07 per share over the past year, against $131.50 at its worst in mid-2022.
KRRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2021 | $9.4M | +10% |
| Q1 2021 | $4.7M | -36% |
| Q4 2020 | $10M | +111% |
KRRO's revenue has slid since its 2020 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -3901% | N/A |
| Q3 2025 | -1765% | N/A |
| Q2 2025 | -1863% | N/A |
| Q1 2025 | -981% | N/A |
| Q2 2021 | -186% | -113 points |
| Q1 2021 | -434% | -356 points |
| Q4 2020 | -103% | +35 points |
| Q3 2020 | -48% | N/A |
KRRO's operating margin was −3901% last quarter, down 3715 points from the same quarter a year ago, near the bottom of its range since 2019.
KRRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13M | +$4.4M |
| Q2 2026 | -$17M | +$2.3M |
| Q1 2026 | -$16.1M | +$8.5M |
| Q4 2025 | -$17.8M | -$8.8M |
| Q3 2025 | -$17.4M | +$3.6M |
| Q2 2025 | -$19.4M | +$1.2M |
| Q1 2025 | -$24.6M | +$2.9M |
| Q4 2024 | -$8.9M | +$38.7M |
KRRO has burned cash in almost every quarter: −$64M over the past year, against −$70M the year before.
KRRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +249K shares |
| 1 year | +90% | +8.5M shares |
| 3 years | +2399% | +17.2M shares |
| 5 years | +2519% | +17.2M shares |
| Available history | +2794% | +17.2M shares |
KRRO has 18M diluted shares, up 90% from a year ago.
KRRO Net Leverage
KRRO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KRRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 75.0 | Neutral |
KRRO's weekly RSI is 55 (neutral) and its Stochastic is 75 (neutral).
KRRO PE vs Healthcare Sector
KRRO has no meaningful PE right now: it lost money over the past year.
KRRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.7 | 23% above |
| 20 week MA | $12.2 | 17% above |
| 50 week MA | $11.6 | 23% above |
| 100 week MA | $18.0 | 20% below |
| 200 week MA | $32.3 | 56% below |
KRRO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 56% below its 200-week average.
KRRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $917.0 | $1,686.0 | +84% |
| 2021 | $1,686.0 | $272.0 | -84% |
| 2022 | $272.0 | $129.5 | -52% |
| 2023 | $129.5 | $47.9 | -63% |
| 2024 | $47.9 | $40.0 | -17% |
| 2025 | $40.0 | $8.12 | -80% |
| 2026 YTD | $8.12 | $14.3 | +76% |
KRRO has finished five years in a row lower, and it's up 76% so far in 2026.